Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women Latest Voluson Signature ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced its Venue Family point-of-care ultrasound systems will now feature Caption Guidance, artificial intelligence (AI)-driven ...

Last year, GE Healthcare upgraded its decade-old line of portable ultrasound devices with the launch of the Vscan Air, a wireless, pocket-sized system for whole-body scanning. Almost exactly one year ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of Voluson™ ...

CHICAGO--(BUSINESS WIRE)-- GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid1 cardiovascular ultrasound systems, which includes new features based on ...

GE Healthcare nabbed FDA clearance for its artificial intelligence-powered cardiovascular ultrasound system, designed to help automate and standardize echocardiogram exams. The Ultra Edition package ...

GE Healthcare has announced the latest version of its Vivid E9 cardiovascular ultrasound system has received FDA 510(k) clearance, according to a news release. Features of the Vivid E9 Breakthrough ...

GE HealthCare (NASDAQ:GEHC) said its has launched Vscan Air SL, a handheld wireless ultrasound imaging system for rapid cardiac and vascular assessments. The product is the latest addition to the ...

GE HealthCare has a vision for how it wants to shape the future of ultrasounds. The company wants ultrasound technology to be “used by nearly every clinician in nearly every situation in nearly every ...

GE HealthCare has received European approval for two cardiac imaging devices: a wireless handheld ultrasound and a device capable of running a CT scan without a patient's electrocardiogram signal. The ...

Are we moving closer to the day when diabetes is no longer monitored and managed with blood sugar tests, insulin injections and drug treatments? A GE Research-led team, which includes The Feinstein ...